What Do Zogenix Drug Study Results Mean For GW Pharmaceuticals’ Epidiolex?
Zogenix, Inc. ZGNX 3.37% shares jumped another 5.6 percent Monday morning after exploding higher by 172 percent Sept. 29 in the wake of positive data on anti-epileptic drug ZX008. Shares of GW Pharmaceuticals PLC-ADR GWPH 0.31% plummeted 9.6 percent last Friday as well, and dropped another 2.3 percent Monday as investors see ZX008 as a potential threat to GW’s Epidiolex epilepsy treatment…

